Metabolic Daria podcast

How to Increase GLP-1 Naturally (Without Ozempic)

27.10.2026
0:00
7:28
15 Sekunden vorwärts
15 Sekunden vorwärts

If carbs never seem to fill you up, there's a reason. In a small 1996 study, lean women released a strong GLP-1 response after a carb meal, while women with obesity barely responded.

After a fat meal, both groups responded about the same. GLP-1 is your gut's fullness hormone, and with insulin resistance the carb signal gets much weaker.

In this episode, I walk through how to work with the signal your body still has:

- Why a low-carb or ketogenic diet fits: fat and protein still trigger GLP-1, and ketones turn down ghrelin, your hunger hormone

- Natural GLP-1 boosters: protein first, yerba mate, allulose and a healthy gut microbiome, plus how strong the evidence is for each

- What new research says about GLP-1 drugs

- Why I see the drugs as a temporary bridge for carb cravings: lowest dose, with an exit plan, strength training and real food habits

This episode is for education only and isn't medical advice. Talk to your doctor before starting or changing any medication.


CONNECT WITH ME

Website: http://metabolicdaria.com

YouTube: https://www.youtube.com/@Metabolic-Daria

Instagram: https://www.instagram.com/metabolicdaria/


SOURCES

Ranganath et al. 1996, GLP-1 in obesity (Gut): https://pmc.ncbi.nlm.nih.gov/articles/PMC1383202

GLP-1 defect after lowering fatty acids (Surrey thesis): https://openresearch.surrey.ac.uk/esploro/outputs/doctoral/The-Role-of-Glucagon-Like-Peptide-1-and/99516004402346

GLP-1 before and after weight loss (IJO): https://www.nature.com/articles/0801655.pdf

Ketone drink lowers ghrelin and appetite (2018): https://www.dpag.ox.ac.uk/publications/publication_modal/743590

Ketosis lowers ghrelin, not GLP-1: https://research.regionh.dk/da/publications/acute-ketosis-inhibits-appetite-and-decreases-plasma-concentratio/

Yerba mate and GLP-1 (Nutrients 2025): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11858593/

Allulose and GLP-1 (J Nutr 2022): https://pmc.ncbi.nlm.nih.gov/articles/PMC9071322

Allulose trial protocol (2026): https://www.researchprotocols.org/2026/1/e81857

Whey protein pre-load trial (Diabetologia 2014): https://pubmed.ncbi.nlm.nih.gov/25005331/

Short-chain fatty acids and GLP-1 (Diabetes 2012): https://pubmed.ncbi.nlm.nih.gov/22190648/

Akkermansia human evidence: https://acibademinternational.com/blog/akkermansia-the-next-generation-probiotic-what-human-data-show/

Weight regain after stopping (BMJ 2025): https://bmjgroup.com/stopping-weight-loss-drugs-linked-to-weight-regain-and-reversal-of-heart-health-markers/

Weight regain review (Cambridge 2026): https://www.uspharmacist.com/article/weight-regain-common-after-stopping-glp1-drugs

Muscle vs. liver on GLP-1s (Cell Reports Medicine 2026): https://bioseb.com/en/module/prestablog/news?id=2394

2026 body composition review: https://substance-over-noise.beehiiv.com/p/how-much-muscle-are-glp-1-patients-actually-losing

Regulators on GLP-1s and mental health: https://ro.co/perspectives/glp1s-mental-health/

GLP-1s and suicidality review (2026): https://orb.binghamton.edu/pharmacy_fac/112

Semaglutide and alcohol cravings (JAMA Psychiatry 2025): https://www.emjreviews.com/neurology/news/semaglutide-cuts-alcohol-cravings-in-new-trial/

Low-dose GLP-1 outcomes: https://www.epocrates.com/online/article/is-glp-1-microdosing-effective

Low-dose semaglutide preprint (2026): https://www.preprints.org/manuscript/202606.0636

FDA winds down GLP-1 compounding: https://www.techtarget.com/pharmalifesciences/news/366621720/FDA-winds-down-GLP-1-compounding-policies

Compounded GLP-1 timeline: https://www.americanmedspa.org/news/compounded-glp-1-faq/

Weitere Episoden von „Metabolic Daria“